Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation.

Pfaff S, Philippe C, Nics L, Berroterán-Infante N, Pallitsch K, Rami-Mark C, Weidenauer A, Sauerzopf U, Willeit M, Mitterhauser M, Hacker M, Wadsak W, Pichler V.

Contrast Media Mol Imaging. 2019 Sep 30;2019:4292596. doi: 10.1155/2019/4292596. eCollection 2019.

2.

Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.

Fazekas-Singer J, Berroterán-Infante N, Rami-Mark C, Dumanic M, Matz M, Willmann M, Andreae F, Singer J, Wadsak W, Mitterhauser M, Jensen-Jarolim E.

Oncotarget. 2017 Sep 15;8(47):83128-83141. doi: 10.18632/oncotarget.20914. eCollection 2017 Oct 10.

3.

[(18)F]FMeNER-D2: A systematic in vitro analysis of radio-metabolism.

Rami-Mark C, Eberherr N, Berroterán-Infante N, Vanicek T, Nics L, Lanzenberger R, Hacker M, Wadsak W, Mitterhauser M.

Nucl Med Biol. 2016 Aug;43(8):490-5. doi: 10.1016/j.nucmedbio.2016.05.004. Epub 2016 May 13.

PMID:
27236284
4.

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.

Sigurdardottir HL, Kranz GS, Rami-Mark C, James GM, Vanicek T, Gryglewski G, Kautzky A, Hienert M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Rujescu D, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2016 Mar;37(3):884-95. doi: 10.1002/hbm.23071. Epub 2015 Dec 17.

5.

Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI.

Rami-Mark C, Berroterán-Infante N, Philippe C, Foltin S, Vraka C, Hoepping A, Lanzenberger R, Hacker M, Mitterhauser M, Wadsak W.

EJNMMI Res. 2015 Dec;5(1):113. doi: 10.1186/s13550-015-0113-3. Epub 2015 Jun 10.

6.

Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding.

Baldinger P, Kraus C, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Spies M, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

Neuroimage. 2015 May 1;111:505-12. doi: 10.1016/j.neuroimage.2015.01.049. Epub 2015 Jan 31.

PMID:
25652393
7.

Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporter.

Neudorfer C, Seddik A, Shanab K, Jurik A, Rami-Mark C, Holzer W, Ecker G, Mitterhauser M, Wadsak W, Spreitzer H.

Molecules. 2015 Jan 20;20(1):1712-30. doi: 10.3390/molecules20011712.

8.

Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.

Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu063. doi: 10.1093/ijnp/pyu063.

9.

The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.

Vanicek T, Spies M, Rami-Mark C, Savli M, Höflich A, Kranz GS, Hahn A, Kutzelnigg A, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Volkow ND, Kasper S, Lanzenberger R.

JAMA Psychiatry. 2014 Dec 1;71(12):1340-1349. doi: 10.1001/jamapsychiatry.2014.1226.

10.

Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.

Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

PLoS One. 2014 Sep 4;9(9):e106810. doi: 10.1371/journal.pone.0106810. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113173. Gryglewsky, Gregor [corrected to Gryglewski, Gregor].

11.

Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women.

Stein P, Baldinger P, Kaufmann U, Christina RM, Hahn A, Höflich A, Kranz GS, Savli M, Wadsak W, Mitterhauser M, Winkler D, Kasper S, Lanzenberger R.

Psychoneuroendocrinology. 2014 Aug;46:52-63. doi: 10.1016/j.psyneuen.2014.04.008. Epub 2014 Apr 21.

PMID:
24882158
12.

Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.

Kranz GS, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, Winkler D, Lanzenberger R, Kasper S.

Psychoneuroendocrinology. 2014 Jul;45:1-10. doi: 10.1016/j.psyneuen.2014.03.004. Epub 2014 Mar 20.

PMID:
24845171
13.

Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.

Rami-Mark C, Bornatowicz B, Fink C, Otter P, Ungersboeck J, Vraka C, Haeusler D, Nics L, Spreitzer H, Hacker M, Mitterhauser M, Wadsak W.

Bioorg Med Chem. 2013 Dec 15;21(24):7562-9. doi: 10.1016/j.bmc.2013.10.046. Epub 2013 Nov 7.

PMID:
24262882
14.

[18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.

Rami-Mark C, Zhang MR, Mitterhauser M, Lanzenberger R, Hacker M, Wadsak W.

Nucl Med Biol. 2013 Nov;40(8):1049-54. doi: 10.1016/j.nucmedbio.2013.08.007. Epub 2013 Oct 5.

15.

Reliable set-up for in-loop ¹¹C-carboxylations using Grignard reactions for the preparation of [carbonyl-¹¹C]WAY-100635 and [¹¹C]-(+)-PHNO.

Rami-Mark C, Ungersboeck J, Haeusler D, Nics L, Philippe C, Mitterhauser M, Willeit M, Lanzenberger R, Karanikas G, Wadsak W.

Appl Radiat Isot. 2013 Dec;82:75-80. doi: 10.1016/j.apradiso.2013.07.023. Epub 2013 Aug 3.

Supplemental Content

Loading ...
Support Center